Universal Beteiligungs Und Servicegesellschaft Mb H Crinetics Pharmaceuticals, Inc. Transaction History
Universal Beteiligungs Und Servicegesellschaft Mb H
- $47.1 Billion
- Q1 2025
A detailed history of Universal Beteiligungs Und Servicegesellschaft Mb H transactions in Crinetics Pharmaceuticals, Inc. stock. As of the latest transaction made, Universal Beteiligungs Und Servicegesellschaft Mb H holds 342,734 shares of CRNX stock, worth $11.5 Million. This represents 0.02% of its overall portfolio holdings.
Number of Shares
342,734
Previous 334,783
2.37%
Holding current value
$11.5 Million
Previous $17.1 Million
32.84%
% of portfolio
0.02%
Previous 0.04%
Shares
2 transactions
Others Institutions Holding CRNX
# of Institutions
246Shares Held
82.1MCall Options Held
26.1KPut Options Held
11.8K-
Vanguard Group Inc Valley Forge, PA9.09MShares$306 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.23MShares$210 Million0.01% of portfolio
-
Driehaus Capital Management LLC Chicago, IL6.14MShares$207 Million3.06% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.41MShares$182 Million0.03% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA4.29MShares$144 Million10.24% of portfolio
About Crinetics Pharmaceuticals, Inc.
- Ticker CRNX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 53,752,800
- Market Cap $1.81B
- Description
- Crinetics Pharmaceuticals, Inc., a clinical stage pharmaceutical company, focuses on the discovery, development, and commercialization of therapeutics for rare endocrine diseases and endocrine-related tumors. Its lead product candidate is Paltusotine, an oral selective nonpeptide somatostatin receptor type 2 agonist that has completed phase III ...